ESC Premium Access

The effect of metformin on mortality rates and exercise tolerance in patients with heart failure and type 2 diabetes.

Topic: Pharmacologic therapy

Presentation

About the speaker

Mr Arkadiusz Retwinski

Medical University of Lodz, Department of Cardiology and Cardiac Surgery, Lodz (Poland)
0 follower

8 more presentations in this session

Are beta-blockers needed in patients after primary prevention implantable cardioverter-defibrillator? A multicenter population-based cohort study.

Speaker: Professor L. Fauchier (Tours, FR)

Thumbnail

Non-withdrawal of beta-blockers in acute decompensated chronic and de-novo heart failure is associated with lower in-hospital and 3-months mortality: Findings from the GULF-CARE

Speaker: Assistant Professor C. Abi Khalil (Doha, QA)

Thumbnail

Beta-blockers, ACE/ARB and MRA at discharge and outcome after hospitalization of heart failure in octogenarians with HFPEF and HFREF: a report from the BIO-HF registry

Speaker: Professor J. De Sutter (Gent, BE)

Thumbnail

Fingerprint of the renin-angiotensin-system during ARNI therapy in patients with systolic heart failure

Speaker: Doctor R. Wurm (Vienna, AT)

Thumbnail

Anti hypertrophic effects of LCZ696 in chronic cardiac pressure overload

Speaker: Mr E. Sjaastad Norden (Oslo, NO)

Thumbnail

Access the full session

Drug therapy of heart failure

Speakers: Mr A. Retwinski, Professor L. Fauchier, Assistant Professor C. Abi Khalil, Professor J. De Sutter, Doctor R. Wurm...
Thumbnail

About the event

Image

ESC CONGRESS 2016

27 August - 31 August 2016

Sessions Presentations

This platform is supported by

logo Novo Nordisk